Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
Sentynl Therapeutics
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
August 11, 2026